Corporate/M&A (International & Cross-Border)
Global Guide 2024 : USA
Band 4
Contact number
+1 212 918 3000Chambers Review
Hogan Lovells is an internationally oriented firm which combines a well-established presence in the USA and an impressive network of offices in other key jurisdictions throughout Europe, Asia, Australia, the Middle East and Africa. The firm's US presence remains an important contributor to its worldwide success and provides a strong transatlantic platform through frequent collaboration with the firm's London office. Washington, DC serves as a key location for the firm's international trade practice, while the firm's US base also plays a significant role in coordinating cross-border advice on regulated industries and M&A transactions.
The firm's lawyers frequently act on upper mid-market M&A emanating from the USA and on inbound investment. Its presence across global markets attracts a broad range of clients engaged in cross-border activity, and the firm's services are particularly utilised across the transatlantic nexus, due to its strong corporate presence in Europe and its London hub. The firm advises on a range of M&A transactions across industries, benefiting from strong US-based groups focused on healthcare, life sciences, energy and infrastructure.
Strengths
Provided by Chambers
"Hogan Lovells is my first choice for complex international transactions. Their understanding and experience goes far beyond the mere legal advice."
"One of the great things about Hogan Lovells is its broad global reach."
"Hogan Lovells is my first choice for complex international transactions. Their understanding and experience goes far beyond the mere legal advice."
"One of the great things about Hogan Lovells is its broad global reach."
Notable Practitioners
Jane Ross is sought after by a host of significant technology and pharmaceutical companies for counsel in high-value M&A.
Keith Flaum focuses his practice on the representation of major public and private companies in high-end domestic and international M&A.
Richard Climan retains an enviable position at the upper echelon of the corporate market. He has an impressive track record acting in transformative transactions in the technology and life sciences sectors.